Laporan Kasus: COVID-19 dengan ARDS Berat dan Komorbiditas yang Bertahan tanpa Ventilasi Mekanik Invasif di ICU Rumah Sakit Darurat COVID-19 Wisma Atlet Kemayoran, Jakarta
Abstract
Sebagian besar orang yang terinfeksi COVID-19 asimtomatis ataupun bergejala ringan. Namun tidak sedikit juga yang mengalami acute respiratory distress syndrome (ARDS), membutuhkan perawatan ICU bahkan berakhir dengan kematian. Indonesia bahkan telah melampaui angka dunia dengan angka 2,7%. Keadaan ini lebih berisiko dialami oleh pasien dengan komorbid seperti hipertensi (50,1%), diabetes (36,6%), dan obesitas (13,3%). Kebutuhan terapi oksigen dengan ventilasi mekanik hingga tindakan intubasi meningkat pada kebanyakan kasus dengan komorbid. Serial kasus ini melaporkan dua pasien terkonfirmasi COVID-19 dengan komorbid yang memenuhi kriteria intubasi, namun tidak dilakukan. Dalam perjalanannya kedua kasus mengalami perbaikan klinis dan sembuh. Beberapa kemungkinan yang dapat dijelaskan, yaitu terdapat perbedaan antara ARDS pada COVID-19 (CARDS) dan ARDS klasik. Selain itu, prone position yang membantu meningkatkan oksigenasi dan mengatasi hipoksemia melalui beberapa mekanisme. Penggunaan HFNC dini pada pasien COVID-19 dan pemberian regimen kombinasi terapi antibiotik, antivirus, antikoagulan, serta antiinflamasi dinilai dapat menurunkan morbiditas pasien. Tujuan penanganan ARDS ialah menangani hipoksemia dengan meningkatkan oksigenasi. Selain dengan pemberian terapi oksigen untuk meningkatkan FiO2, dapat juga dilakukan dengan prone position. Prone position pada kasus dengan kombinasi HFNC dinilai berhasil karena pasien mampu bertahan tanpa penggunaan ventilasi mekanik dan mengalami perbaikan klinis hingga sembuh.
Two Reported Cases of COVID-19 with Severe ARDS and Comorbidities who Survived without Invasive Mechanical Ventilation in ICU at Wisma Atlet Kemayoran COVID-19 Field Hospital, Jakarta
Most patients with COVID-19 are either asymptomatic or have mild symptoms. However, many also experience acute respiratory distress syndrome (ARDS), requiring ICU, or even lead to death. Indonesia’s case fatality rate of 2.7% has exceeded the global case. Patients with comorbidities such as hypertension (50.1%), diabetes (36.6%), and obesity (13.3%) are at higher risk of experiencing this situation. The need for oxygen therapy with mechanical ventilation or even intubation is increased in most cases with previously mentioned comorbidities. These serial cases reported two confirmed COVID-19 patients with comorbidities that fulfilled intubation criteria; however, the intubation procedures were not performed. Both cases experienced clinical improvement and improved throughout the treatment period. Several possible explanations include that there are differences between ARDS in COVID-19 (CARDS) and classic ARDS. Moreover, the prone position helps in increasing oxygenation and reducing hypoxemia through several mechanisms. Early HFNC in COVID-19 patients and treatment regimen consisting of antibiotics, antivirus, anticoagulant, and anti-inflammatory drugs are considered to reduce morbidity. The goal of ARDS treatment is to treat hypoxemia by increasing oxygenation. In addition, giving oxygen therapy to increase FiO2 can also be done by prone positioning. Combining prone position and HFNC in these cases was considered successful because the patient were able to survive without the use of mechanical ventilation and experienced clinical improvement until they recovered.
Keywords
Full Text:
PDFReferences
Huang Y, Lu Y, Huang Y-M, Wang M, Ling W, Sui Y, dkk. Obesity in patients with COVID-19: a systematic review and meta-analysis. Metab Clin Exp. 2020;113:1–11.
WHO. WHO Coronavirus (COVID-19) dashboard: overview [Internet]. 2021 [diunduh 4 Mei 2021]. Tersedia dari: https://covid19.who.int.
Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan H, dkk. Coronavirus disease 2019: tinjauan literatur terkini. J Penyakit Dalam Indones. 2020;7(1):45.
Cao J, Hu X, Cheng W, Yu L, Tu WJ, Liu Q. Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit. Intens Care Med. 2020;46(5):851–3.
Lippi G, Henry BM, Mattiuzzi C, Bovo C. COVID-19 virus case fatality rate: how to avoid errors in calculation of data during the outbreak? Acta Biomed. 2020; 91(2):224–5.
Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, dkk. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. 2020;8(5):506–17.
Abate SM, Ali SA, Mantfardo B, Basu B. Rate of intensive care unit admission and outcomes among patients with coronavirus: a systematic review and Meta-analysis. PLoS One. 2020 Juli;15:1–19.
Kemenkes RI. Sistem Informasi Rumah Sakit Darurat COVID-19 [Internet]. 2021 [diunduh 22 April 2021]. Tersedia dari: http://simrsdc.kemkes.go.id/.
Schmidt M, Hajage D, Demoule A, Pham T, Combes A, Dres M, dkk. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intens Care Med. 2021;47(1):60–73.
Soeroto AY, Hartantri Y, Perkusi JE, Ferdian F, Rehimat U, Suryadinata H. Report of two COVID-19 ARDS (CARDS) cases who survived without intubation and mechanical ventilation. Acta Med Indones. 2020;52(3):274–82.
Soedarsono S, Semedi BP, Setiawati R, Meliana RY, Kusmiati T, Permatasari A, dkk. Case report: survival of a coronavirus disease-2019 (Covid-19) patient with acute respiratory distress syndrome (ARDS) in Dr. Soetomo Hospital, Surabaya, Indonesia. Folia Medica Indones. 2021;56(3):235.
Confalonieri M, Salton F, Fabiano F. Acute respiratory distress syndrome. Eur Respir Rev. 2017;26(144):160116.
Bakhtiar A, Maranatha RA. Acute respiratory distress syndrome. J Respirasi. 2018;4(2):51–60.
Brinkman JE, Sharma S. Respiratory alkalosis [Internet]. StatPearls. 2021 [diunduh 3 Juni 2021]. Tersedia dari: https://www.ncbi.nlm.nih.gov/books/NBK482117/.
Wu C, Wang G, Zhang Q, Yu B, Lv J, Zhang S, dkk. Association between respiratory alkalosis and the prognosis of COVID-19 patients. Front Med. 2021;8:6–11.
Seers T, Davenport R. Phosphate metabolism and respiratory alkalosis: a forgotten lesson in COVID-19. Age Ageing. 2020;49(6):927.
Zhang C, Wu Z, Li J, Zhao H, Wang G. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist. Int J Antimicrob Agents. 2020;55(2020):105954–60.
Karyono DR, Wicaksana AL. Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. J Community Empower Heal. 2020;3(2):77.
Chiumello D, Pozzi T, Storti E, Caccioppola A, Pontiroli AE, Coppola S. Body mass index and acute respiratory distress severity in patients with and without SARS-CoV-2 infection. Br J Anaesth. 2020;125(4):376–7.
Paul V, Patel S, Royse M, Odish M, Malhotra A, Koenig S. Proning in non-intubated (PINI) in times of COVID-19: case series and a review. J Intens Care Med. 2020;35(8):818–24.
Sztajnbok J, Maselli-Schoueri JH, Cunha de Resende Brasil LM, Farias de Sousa L, Cordeiro CM, Sansão Borges LM, dkk. Prone positioning to improve oxygenation and relieve respiratory symptoms in awake, spontaneously breathing non-intubated patients with COVID-19 pneumonia. Respir Med Case Reports. 2020;30:101096.
Koeckerling D, Barker J, Mudalige NL, Oyefeso O, Pan D, Pareek M, dkk. Awake prone positioning in COVID-19. Thorax. 2020;75(10):833–4.
Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA. 2020;323(22):2329–30.
Jahani S, Hajivand Soleymani Z, Asadizaker M, Soltani F, Cheraghian B. Determination of the effects of prone position on oxygenation in patients with acute respiratory failure under mechanical ventilation in ICU. J Med Life. 2018;11(4):274–80.
Abroug F, Ouanes-Besbes L, Elatrous S, Brochard L. The effect of prone positioning in acute respiratory distress syndrome or acute lung injury: a meta-analysis. Areas of uncertainty and recommendations for research. Intens Care Med. 2008;34 (6):1002–11.
Kemenkes RI. Protokol tata laksana COVID-19 Buku Saku. Jakarta: Kementrian Kesehatan Republik Indonesia. 2020.
DOI: https://doi.org/10.15851/jap.v9n2.2457
Article Metrics
Abstract view : 3779 timesPDF - 2331 times
This Journal indexed by
JAP is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
View My Stats